Literature DB >> 17497486

Promotional methods used by representatives of drug companies: a prospective survey in general practice.

Jesper Schramm1, Morten Andersen, Kirstin Vach, Jakob Kragstrup, Jens Peter Kampmann, Jens Søndergaard.   

Abstract

OBJECTIVE: To examine the extent and composition of pharmaceutical industry representatives' marketing techniques with a particular focus on drug sampling in relation to drug age.
DESIGN: A group of 47 GPs prospectively collected data on drug promotional activities during a six-month period, and a sub-sample of 10 GPs furthermore recorded the representatives' marketing techniques in detail.
SETTING: Primary healthcare.
SUBJECTS: General practitioners in the County of Funen, Denmark. MAIN OUTCOME MEASURES: Promotional visits and corresponding marketing techniques.
RESULTS: The 47 GPs recorded 1050 visits corresponding to a median of 19 (range 3 to 63) per GP in the six months. The majority of drugs promoted (52%) were marketed more than five years ago. There was a statistically significant decline in the proportion of visits where drug samples were offered with drug age, but the decline was small OR 0.97 (95% CI 0.95;0.98) per year. Leaflets (68%), suggestions on how to improve therapy for a specific patient registered with the practice (53%), drug samples (48%), and gifts (36%) were the most frequently used marketing techniques.
CONCLUSION: Drug-industry representatives use a variety of promotional methods. The tendency to hand out drug samples was statistically significantly associated with drug age, but the decline was small.

Entities:  

Mesh:

Year:  2007        PMID: 17497486      PMCID: PMC3379754          DOI: 10.1080/02813430701339659

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  20 in total

1.  Physicians and the pharmaceutical industry: is a gift ever just a gift?

Authors:  A Wazana
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

2.  Failures of the therapeutic chain as a cause of drug ineffectiveness.

Authors:  Albert Figueras; Joan-Ramon Laporte
Journal:  BMJ       Date:  2003-04-26

3.  No more free lunches.

Authors:  Kamran Abbasi; Richard Smith
Journal:  BMJ       Date:  2003-05-31

4.  Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.

Authors:  Philip Rutledge; David Crookes; Brian McKinstry; Simon R Maxwell
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-12       Impact factor: 2.890

5.  Prescription drug samples--does this marketing strategy counteract policies for quality use of medicines?

Authors:  K E M Groves; I Sketris; S E Tett
Journal:  J Clin Pharm Ther       Date:  2003-08       Impact factor: 2.512

6.  New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.

Authors:  Helen Prosser; Tom Walley
Journal:  Fam Pract       Date:  2003-10       Impact factor: 2.267

7.  Doctors and drug companies.

Authors:  David Blumenthal
Journal:  N Engl J Med       Date:  2004-10-28       Impact factor: 91.245

8.  The role of commercial sources in the adoption of a new drug.

Authors:  M Y Peay; E R Peay
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

9.  Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.

Authors:  C Watkins; I Harvey; P Carthy; L Moore; E Robinson; R Brawn
Journal:  Qual Saf Health Care       Date:  2003-02

10.  Influences on GPs' decision to prescribe new drugs-the importance of who says what.

Authors:  Helen Prosser; Solomon Almond; Tom Walley
Journal:  Fam Pract       Date:  2003-02       Impact factor: 2.267

View more
  4 in total

1.  Knowledge levels of pharmaceutical sales representatives in pain therapy: a descriptive questionnaire-based study.

Authors:  Christoph L Lassen; Kirstin Fragemann; Tobias Klier; Nicole Meyer; Bernhard M Graf; Christoph H R Wiese
Journal:  Eur J Clin Pharmacol       Date:  2011-07-30       Impact factor: 2.953

2.  GPs' opinions of public and industrial information regarding drugs: a cross-sectional study.

Authors:  Ingmarie Skoglund; Cecilia Björkelund; Kirsten Mehlig; Ronny Gunnarsson; Margareta Möller
Journal:  BMC Health Serv Res       Date:  2011-08-25       Impact factor: 2.655

3.  Dose adjustment of antidiabetic medications in chronic kidney disease.

Authors:  Matthew Salvatore Snyder; Joshua Fogel; Svetlana Pyatigorskaya; Sofia Rubinstein
Journal:  Avicenna J Med       Date:  2021-01-05

4.  Influence of Sales Promotion Techniques on Consumers' Purchasing Decisions at Community Pharmacies.

Authors:  Younes Ben Said; Nicola Luigi Bragazzi; Natalia Valeryevna Pyatigorskaya
Journal:  Pharmacy (Basel)       Date:  2019-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.